help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukumura, D.
Right arrow Articles by Jain, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukumura, D.
Right arrow Articles by Jain, R. K.

American Journal of Pathology, Vol 151, 679-688, Copyright © 1997 by American Society for Investigative Pathology


REGULAR ARTICLES

Effect of host microenvironment on the microcirculation of human colon adenocarcinoma

D Fukumura, F Yuan, WL Monsky, Y Chen and RK Jain
Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital, Boston 02114, USA.

It is generally accepted that the host microenvironment influences tumor biology. There are discrepancies in growth rate, metastatic potential, and efficacy of systemic treatment between ectopic and orthotopic tumors. Liver is the most common and critical site of distant metastasis of colorectal carcinoma. Tumorigenicity and efficacy of chemotherapeutic agents in colorectal tumors are different in liver and subcutaneous sites. Thus, we hypothesize that the liver (orthotopic) versus subcutaneous (ectopic) microenvironment would have different effects on the angiogenesis and maintenance of the microcirculation of colorectal tumor. To this end, we developed a new method to monitor and to quantify microcirculatory parameters in the tumor grown in the liver. Using this approach, we compared the microcirculation of LS174T, a human colon adenocarcinoma, metastasized to the liver with that of the host liver vessels and that of the same tumor grown in the subcutaneous space. In the liver metastasis model, 5 x 10(6) LS174T cells were injected into the spleen of nude mice. Four to eight weeks later, the liver with metastatic tumors was exteriorized and placed on a special stage and observed under an intravital fluorescence microscope. The dorsal skinfold chamber model was used to study the subcutaneous tumors. Red blood cell velocity, vessel diameter, density, permeability, and leukocyte-endothelial interactions were measured using fluorescence microscopy and image analysis. Vascular endothelial growth factor/ vascular permeability factor (VEGF/VPF) mRNA expression was determined by the Northern blot analysis. LS174T tumor foci in the liver had tortuous vascular architecture, heterogeneous blood flow, significantly lower vascular density, and significantly higher vascular permeability than normal liver tissue. Tumors grown in the liver had significantly lower vessel density, especially in the center coincident with central necrosis, than the subcutaneous tumors. The frequency distribution of vessel diameters of liver tumor was slightly shifted to smaller size compared with that of subcutaneous tumor. Leukocyte rolling in liver tumor was twofold lower than that in subcutaneous tumor. These physiological findings were consistent with the measurement of VEGF/VPF in that the VEGF/VPF mRNA level was lower in the liver tumor than that in the subcutaneous tumor. However, macromolecular vascular permeability in the liver tumor was significantly higher than in the subcutaneous tumor. Liver sinusoidal endothelial cells, the origin of liver tumor vessel endothelium, are known to be fenestrated and not to have a basement membrane, suggesting that the difference in endothelial cell origin may explain the difference in tumor vascular permeability in two sites. These findings demonstrate that liver microenvironment has different effects on some aspects of the tumor angiogenesis and microcirculation compared with the subcutaneous tissues. The new model/method described in this paper has significant implications in two research areas: 1) the liver microenvironment and its effect on tumor pathophysiology in conjunction with cytokine/ growth factor regulation and 2) the delivery of drugs, cells, and genes to liver tumors.


This article has been cited by other articles:


Home page
RadiologyHome page
Y. Liu and O. Matsui
Changes of Intratumoral Microvessels and Blood Perfusion during Establishment of Hepatic Metastases in Mice
Radiology, May 1, 2007; 243(2): 386 - 395.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Solban, S. K. Pal, S. K. Alok, C. K. Sung, and T. Hasan
Mechanistic Investigation and Implications of Photodynamic Therapy Induction of Vascular Endothelial Growth Factor in Prostate Cancer
Cancer Res., June 1, 2006; 66(11): 5633 - 5640.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. E. Stewart, X. Chen, J. Hadway, and T.-Y. Lee
Correlation between Hepatic Tumor Blood Flow and Glucose Utilization in a Rabbit Liver Tumor Model
Radiology, June 1, 2006; 239(3): 740 - 750.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. di Tomaso, D. Capen, A. Haskell, J. Hart, J. J. Logie, R. K. Jain, D. M. McDonald, R. Jones, and L. L. Munn
Mosaic Tumor Vessels: Cellular Basis and Ultrastructure of Focal Regions Lacking Endothelial Cell Markers
Cancer Res., July 1, 2005; 65(13): 5740 - 5749.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Aalinkeel, M. P. N. Nair, G. Sufrin, S. D. Mahajan, K. C. Chadha, R. P. Chawda, and S. A. Schwartz
Gene Expression of Angiogenic Factors Correlates with Metastatic Potential of Prostate Cancer Cells
Cancer Res., August 1, 2004; 64(15): 5311 - 5321.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. B. Kruskal, P. Thomas, R. A. Kane, and S. N. Goldberg
Hepatic Perfusion Changes in Mice Livers with Developing Colorectal Cancer Metastases
Radiology, May 1, 2004; 231(2): 482 - 490.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. O. Schmidt, M. Ziu, G. Carrabba, C. Giussani, L. Bello, Y. Sun, K. Schmidt, M. Albert, P. Mcl. Black, and R. S. Carroll
Antiangiogenic Therapy by Local Intracerebral Microinfusion Improves Treatment Efficiency and Survival in an Orthotopic Human Glioblastoma Model
Clin. Cancer Res., February 15, 2004; 10(4): 1255 - 1262.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
O. Stoeltzing, W. Liu, N. Reinmuth, A. Parikh, S. A. Ahmad, Y. D. Jung, F. Fan, and L. M. Ellis
Angiogenesis and Antiangiogenic Therapy of Colon Cancer Liver Metastasis
Ann. Surg. Oncol., August 1, 2003; 10(7): 722 - 733.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. Amano, I. Hayashi, H. Endo, H. Kitasato, S. Yamashina, T. Maruyama, M. Kobayashi, K. Satoh, M. Narita, Y. Sugimoto, et al.
Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth
J. Exp. Med., January 20, 2003; 197(2): 221 - 232.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. D. Braun, A. Abbas, S. O. Bukhari, and W. Wilson III
Hemodynamic Parameters in Blood Vessels in Choroidal Melanoma Xenografts and Rat Choroid
Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3045 - 3052.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. L. Monsky, C. M. Carreira, Y. Tsuzuki, T. Gohongi, D. Fukumura, and R. K. Jain
Role of Host Microenvironment in Angiogenesis and Microvascular Functions in Human Breast Cancer Xenografts: Mammary Fat Pad versus Cranial Tumors
Clin. Cancer Res., April 1, 2002; 8(4): 1008 - 1013.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Shan, A. C. Lockhart, W. Y. Saito, A. M. Knapp, K. R. Laderoute, and M. W. Dewhirst
The Novel Tubulin-binding Drug BTO-956 Inhibits R3230Ac Mammary Carcinoma Growth and Angiogenesis in Fischer 344 Rats
Clin. Cancer Res., August 1, 2001; 7(8): 2590 - 2596.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. A. Teicher, K. Menon, E. Alvarez, E. Galbreath, C. Shih, and M. Faul
Antiangiogenic and Antitumor Effects of a Protein Kinase C{beta} Inhibitor in Human T98G Glioblastoma Multiforme Xenografts
Clin. Cancer Res., March 1, 2001; 7(3): 634 - 640.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
D. J. Brat and E. G. Van Meir
Glomeruloid Microvascular Proliferation Orchestrated by VPF/VEGF : A New World of Angiogenesis Research
Am. J. Pathol., March 1, 2001; 158(3): 789 - 796.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. J. Lim, M. J. Parr, D. Masin, N. L. McIntosh, T. D. Madden, G. Zhang, S. Johnstone, and M. B. Bally
Kupffer Cells Do Not Play a Role in Governing the Efficacy of Liposomal Mitoxantrone Used to Treat a Tumor Model Designed to Assess Drug Delivery to Liver
Clin. Cancer Res., November 1, 2000; 6(11): 4449 - 4460.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. H. Wang, A. R. McIntosh, B. B. Hasinoff, E. S. Rector, N. Ahmed, D. M. Nance, and F. W. Orr
B16 Melanoma Cell Arrest in the Mouse Liver Induces Nitric Oxide Release and Sinusoidal Cytotoxicity: A Natural Hepatic Defense against Metastasis
Cancer Res., October 1, 2000; 60(20): 5862 - 5869.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. C. Hartford, T. Gohongi, D. Fukumura, and R. K. Jain
Irradiation of a Primary Tumor, Unlike Surgical Removal, Enhances Angiogenesis Suppression at a Distal Site: Potential Role of Host-Tumor Interaction
Cancer Res., April 1, 2000; 60(8): 2128 - 2131.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
T. A. Drixler, I. H. M. B. Rinkes, E. D. Ritchie, T. J. M. V. van Vroonhoven, M. F. B. G. Gebbink, and E. E. Voest
Continuous Administration of Angiostatin Inhibits Accelerated Growth of Colorectal Liver Metastases after Partial Hepatectomy
Cancer Res., March 1, 2000; 60(6): 1761 - 1765.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. S. Yoon, H. Eto, C.-m. Lin, H. Nakamura, T. M. Pawlik, S. U. Song, and K. K. Tanabe
Mouse Endostatin Inhibits the Formation of Lung and Liver Metastases
Cancer Res., December 1, 1999; 59(24): 6251 - 6256.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. C. Drummond, O. Meyer, K. Hong, D. B. Kirpotin, and D. Papahadjopoulos
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Pharmacol. Rev., December 1, 1999; 51(4): 691 - 744.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. M. Loadman, M. C. Bibby, J. A. Double, W. M. Al-Shakhaa, and R. Duncan
Pharmacokinetics of PK1 and Doxorubicin in Experimental Colon Tumor Models with Differing Responses to PK1
Clin. Cancer Res., November 1, 1999; 5(11): 3682 - 3688.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. Molnar, I. Fekete, K. E. Schlageter, G. D. Lapin, and D. R. Groothuis
Absence of Host-Site Influence on Angiogenesis, Blood Flow, and Permeability in Transplanted RG-2 Gliomas
Drug Metab. Dispos., September 1, 1999; 27(9): 1085 - 1091.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
W. L. Monsky, D. Fukumura, T. Gohongi, M. Ancukiewcz, H. A. Weich, V. P. Torchilin, F. Yuan, and R. K. Jain
Augmentation of Transvascular Transport of Macromolecules and Nanoparticles in Tumors Using Vascular Endothelial Growth Factor
Cancer Res., August 1, 1999; 59(16): 4129 - 4135.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. G. Roberts, J. Delaat, M. Nagane, S. Huang, W. K. Cavenee, and G. E. Palade
Host Microvasculature Influence on Tumor Vascular Morphology and Endothelial Gene Expression
Am. J. Pathol., October 1, 1998; 153(4): 1239 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Carmeliet, L. Moons, and D. Collen
Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis
Cardiovasc Res, July 1, 1998; 39(1): 8 - 33.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. K. Hobbs, W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and R. K. Jain
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
PNAS, April 14, 1998; 95(8): 4607 - 4612.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.